New omicron sublineages surge, but Pfizer-BioNTech bivalent booster retains effectiveness Post author: Post published:October 30, 2023 Post category:uncategorized The efficacy of the bivalent Pfizer-BioNTech COVID-19 messenger ribonucleic acid (mRNA) vaccine BNT162b2 BA.4/5. You Might Also Like Uncovering new antibiotics from the human gut microbiome August 19, 2024 Study finds microplastics in semen and urine, linking PTFE exposure to lower sperm count October 1, 2024 Widespread inhaler misuse in COPD patients: Need for training August 25, 2024
Study finds microplastics in semen and urine, linking PTFE exposure to lower sperm count October 1, 2024